Cyclin D1 anticorps (AA 1-233) (FITC)
-
- Antigène Voir toutes Cyclin D1 (CCND1) Anticorps
- Cyclin D1 (CCND1)
-
Épitope
- AA 1-233
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Cyclin D1 est conjugé à/à la FITC
- Application
- Veuillez nous consulter SVP
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human B-cell lymphoma/leukemia 10 protein (1-233AA)
- Isotype
- IgG
- Top Product
- Discover our top product CCND1 Anticorps primaire
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- Cyclin D1 (CCND1)
- Autre désignation
- BCL1 (CCND1 Produits)
- Synonymes
- anticorps BCL1, anticorps D11S287E, anticorps PRAD1, anticorps U21B31, anticorps AI327039, anticorps CycD1, anticorps Cyl-1, anticorps bcl-1, anticorps cD1, anticorps cb161, anticorps cycd1, anticorps etID37810.7, anticorps fb52e01, anticorps fc45c08, anticorps fc83a12, anticorps id:ibd1198, anticorps wu:fb52e01, anticorps wu:fc45c08, anticorps wu:fc83a12, anticorps ccnd1b, anticorps prad1, anticorps ccnd1, anticorps ccnd1a, anticorps bcl1, anticorps d11s287e, anticorps u21b31, anticorps CCND1, anticorps cyclin D1, anticorps cyclin D1 S homeolog, anticorps cyclin D1 L homeolog, anticorps CCND1, anticorps Ccnd1, anticorps ccnd1, anticorps ccnd1.S, anticorps ccnd1.L
- Sujet
-
Background: Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK. May be an adapter protein between upstream TNFR1-TRADD-RIP complex and the downstream NIK-IKK-IKAP complex. Is a substrate for MALT1.
Aliases: AI132454 antibody, B cell CLL/lymphoma 10 antibody, B cell lymphoma/leukemia10 antibody, B-cell CLL/lymphoma 10 antibody, B-cell leukemia/lymphoma 10 antibody, B-cell lymphoma/leukemia 10 antibody, Bcl 10 antibody, Bcl-10 antibody, Bcl10 antibody, BCL10_HUMAN antibody, c E10 antibody, c-E10 antibody, C81403 antibody, CARD containing apoptotic signaling protein antibody, CARD containing molecule enhancing NF kappa B antibody, CARD containing molecule enhancing NF kB antibody, CARD containing molecule enhancing NF-kB antibody, CARD containing molecule enhancing NFkB antibody, CARD containing proapoptotic protein antibody, CARD like apoptotic protein antibody, CARD-containing apoptotic signaling protein antibody, CARD-containing molecule enhancing NF-kappa-B antibody, CARD-containing proapoptotic protein antibody, CARD-like apoptotic protein antibody, CARMEN antibody, Caspase recruiting domain containing protein antibody, caspase-recruiting domain-containing protein antibody, cCARMEN antibody, cE 10 antibody, cE10 antibody, CED 3/ICH 1 prodomain homologous E10 like regulator antibody, CED-3/ICH-1 prodomain homologous E10-like regulator antibody, CED3/ICH1 prodomain homologous E10 like regulator antibody, Cellular E10 antibody, Cellular homolog of vCARMEN antibody, Cellular-E10 antibody, CIPER antibody, CLAP antibody, hCLAP antibody, Mammalian CARD containing adapter molecule E10 antibody, Mammalian CARD-containing adapter molecule E10 antibody, mE 10 antibody, mE10 antibody, R-RCD1 antibody
- UniProt
- O95999
- Pathways
- Signalisation PI3K-Akt, Cycle Cellulaire, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
-